Latest News

A Danish registry study found that COVID-19 infection was linked to a lower, not higher, risk of subsequent type 1 diabetes (T1D) in unvaccinated individuals under 30 years of age.

A high-dose vaccine cut hospitalizations for flu, pneumonia, and cardiorespiratory disease in older adults with asthma, COPD, and other chronic lung conditions.

The data support GPRC5D-directed CAR T-cell therapy as a potential option following prior BCMA-targeted treatment.

Investing in formalized technician education not only supports competency development but also strengthens workforce stability.

Student pharmacists have the unique position to encourage patient glucose monitoring through continuous glucose monitors (CGMs) and pilot initiatives to address provider, racial, and cost barriers.

The DAPA ACT HF-TIMI 68 analysis shows early, sustained congestion relief and rising diuretic efficiency through 2 months.

The FDA expanded the accelerated approval of sevabertinib to include treatment-naive adults with locally advanced or metastatic non-squamous NSCLC harboring HER2 tyrosine kinase domain activating mutations.

The investigational IL-33–targeting monoclonal antibody tozorakimab reduced moderate-to-severe COPD exacerbations across 2 phase 3 trials, including among patients with low blood eosinophil counts.

Health systems are being urged to reconcile inventory immediately, as the affected vials are commonly stocked for anaphylaxis and septic shock emergencies.

A 5-level model for classifying AI-enabled pharmacy systems may help health systems advance to new levels of pharmacy autonomy.

Pharmacists rethink retirement: use compound growth, start early, and define the life you want—so your savings plan fits your future.

Lurking under the surface of inroads made toward better reimbursement and expanded scope of practice are major workforce supply challenges.

Camizestrant is the first cancer therapy guided by a ctDNA resistance mutation detected before imaging shows disease progression.

Preclinical research identifies tumor-secreted PRDX1 as a potential “redox checkpoint” that suppresses T-cell activity and may contribute to resistance to immune checkpoint inhibitors.

Titilola M. Afolabi discusses how gaps in pediatric-specific evidence shaped her path into research and highlights the interdisciplinary studies that have defined her career.

Clear governance, appropriate oversight, and alignment among technology, policy, and payment will be essential.

A single-center study found similar 12-month total weight loss whether or not patients used a glucagon-like peptide-1 (GLP-1) receptor agonist before surgery.

Long-lived monocyte-derived cells in the lung help sustain tissue-resident memory T cells after influenza infection, and researchers say the discovery could inform more effective nasal flu vaccines.

A prospective multicenter study found high response rates with first-line obinutuzumab plus bendamustine across several indolent B-cell lymphoma subtypes, although short follow-up and the absence of a comparator limit conclusions about long-term benefit.

An ifosfamide shortage prompts cancer treatment concerns and new importation efforts.

Blood Cancer Awareness Month highlights types of blood cancer and how pharmacists flag multiple myeloma symptoms early, speeding referral and care.